Efficacy and Safety of Non-Steroidal Mineralocorticoid Receptor Antagonists in Patients With Chronic Kidney Disease and Type 2 Diabetes: A Systematic Review Incorporating an Indirect Comparisons Meta-Analysis

Background: The non-steroidal mineralocorticoid receptor antagonists (MRAs) are promising treatments in patients with chronic kidney disease (CKD) and type 2 diabetes (T2D). We conducted a meta-analysis to explore the efficacy and safety of the non-steroidal MRAs (finerenone, apararenone, esaxerenon...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Xinrui, Zhang, Zhengji, Li, Chunlu, Zhang, Shijin, Su, Qiang, Yang, Siyun, Liu, Xin, Hu, Ying, Pu, Xiaofeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243561/
https://www.ncbi.nlm.nih.gov/pubmed/35784710
http://dx.doi.org/10.3389/fphar.2022.896947

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243561/
https://www.ncbi.nlm.nih.gov/pubmed/35784710
http://dx.doi.org/10.3389/fphar.2022.896947

Ejemplares similares